Altered energy metabolism in cancer

References

• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 74; http://dx.doi.org/10.1016/j.cell.2011.02.013; PMID: 21376230
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science 1956; 123:309 - 14; http://dx.doi.org/10.1126/science.123.3191.309; PMID: 13298683
   PubMed Web of Science ®Google Scholar
• Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2:683 - 93; http://dx.doi.org/10.1038/nrc882; PMID: 12209157
   PubMed Web of Science ®Google Scholar
• Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 2011; 27:441 - 64; http://dx.doi.org/10.1146/annurev-cellbio-092910-154237; PMID: 21985671
   PubMed Web of Science ®Google Scholar
• Schornack PA, Gillies RJ. Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors. Neoplasia 2003; 5:135 - 45; PMID: 12659686
   PubMed Web of Science ®Google Scholar
• Smallbone K, Gavaghan DJ, Gatenby RA, Maini PK. The role of acidity in solid tumour growth and invasion. J Theor Biol 2005; 235:476 - 84; http://dx.doi.org/10.1016/j.jtbi.2005.02.001; PMID: 15935166
   PubMed Web of Science ®Google Scholar
• Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11:85 - 95; http://dx.doi.org/10.1038/nrc2981; PMID: 21258394
   PubMed Web of Science ®Google Scholar
• Younes M, Brown RW, Stephenson M, Gondo M, Cagle PT. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 1997; 80:1046 - 51; http://dx.doi.org/10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; PMID: 9305704
   PubMed Web of Science ®Google Scholar
• Kang SS, Chun YK, Hur MH, Lee HK, Kim YJ, Hong SR, et al. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res 2002; 93:1123 - 8; http://dx.doi.org/10.1111/j.1349-7006.2002.tb01214.x; PMID: 12417042
   PubMedGoogle Scholar
• Cao X, Fang L, Gibbs S, Huang Y, Dai Z, Wen P, et al. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemother Pharmacol 2007; 59:495 - 505; http://dx.doi.org/10.1007/s00280-006-0291-9; PMID: 16906425
   PubMed Web of Science ®Google Scholar
• Wolf A, Agnihotri S, Micallef J, Mukherjee J, Sabha N, Cairns R, et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med 2011; 208:313 - 26; http://dx.doi.org/10.1084/jem.20101470; PMID: 21242296
   PubMed Web of Science ®Google Scholar
• Pedersen PL. Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment’s roles together with hexokinase-2 in the “Warburg effect” in cancer. J Bioenerg Biomembr 2008; 40:123 - 6; http://dx.doi.org/10.1007/s10863-008-9165-7; PMID: 18780167
   PubMed Web of Science ®Google Scholar
• Ko YH, Pedersen PL, Geschwind JF. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett 2001; 173:83 - 91; http://dx.doi.org/10.1016/S0304-3835(01)00667-X; PMID: 11578813
   PubMed Web of Science ®Google Scholar
• Bluemlein K, Grüning NM, Feichtinger RG, Lehrach H, Kofler B, Ralser M. No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis. Oncotarget 2011; 2:393 - 400; PMID: 21789790
   PubMed Web of Science ®Google Scholar
• Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang JK, Shen M, et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011; 334:1278 - 83; http://dx.doi.org/10.1126/science.1211485; PMID: 22052977
   PubMed Web of Science ®Google Scholar
• Goldberg MS, Sharp PA. Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression. J Exp Med 2012; 209:217 - 24; http://dx.doi.org/10.1084/jem.20111487; PMID: 22271574
   PubMed Web of Science ®Google Scholar
• Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfør K, Rofstad EK, et al. High lactate levels predict likelihood of metastases, tumor recurrence and restricted patient survival in human cervical cancers. Cancer Res 2000; 60:916 - 21; PMID: 10706105
   PubMed Web of Science ®Google Scholar
• Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 2010; 107:2037 - 42; http://dx.doi.org/10.1073/pnas.0914433107; PMID: 20133848
   PubMed Web of Science ®Google Scholar
• Yamaguchi R, Janssen E, Perkins G, Ellisman M, Kitada S, Reed JC. Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy. PLoS One 2011; 6:e24102; http://dx.doi.org/10.1371/journal.pone.0024102; PMID: 21949692
   PubMedGoogle Scholar
• Bhardwaj V, Rizvi N, Lai MB, Lai JC, Bhushan A. Glycolytic enzyme inhibitors affect pancreatic cancer survival by modulating its signaling and energetics. Anticancer Res 2010; 30:743 - 9; PMID: 20392992
   PubMed Web of Science ®Google Scholar
• El Sayed SM, El-Magd RM, Shishido Y, Chung SP, Diem TH, Sakai T, et al. 3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects. J Bioenerg Biomembr 2012; 44:61 - 79; http://dx.doi.org/10.1007/s10863-012-9409-4; PMID: 22318356
   PubMed Web of Science ®Google Scholar
• Michelakis ED, Webster L, Mackey JR. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br J Cancer 2008; 99:989 - 94; http://dx.doi.org/10.1038/sj.bjc.6604554; PMID: 18766181
   PubMed Web of Science ®Google Scholar
• Kuo W, Lin J, Tang TK. Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice. Int J Cancer 2000; 85:857 - 64; http://dx.doi.org/10.1002/(SICI)1097-0215(20000315)85:6<857::AID-IJC20>3.0.CO;2-U; PMID: 10709108
   PubMed Web of Science ®Google Scholar
• Varshney R, Dwarakanath B, Jain V. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells. Int J Radiat Biol 2005; 81:397 - 408; http://dx.doi.org/10.1080/09553000500148590; PMID: 16076755
   PubMed Web of Science ®Google Scholar
• Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, Parslow D, et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 2007; 292:C125 - 36; http://dx.doi.org/10.1152/ajpcell.00247.2006; PMID: 16971499
   PubMed Web of Science ®Google Scholar
• Swietach P, Vaughan-Jones RD, Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 2007; 26:299 - 310; http://dx.doi.org/10.1007/s10555-007-9064-0; PMID: 17415526
   PubMed Web of Science ®Google Scholar
• Osthus RC, Shim H, Kim S, Li Q, Reddy R, Mukherjee M, et al. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem 2000; 275:21797 - 800; http://dx.doi.org/10.1074/jbc.C000023200; PMID: 10823814
   PubMed Web of Science ®Google Scholar
• Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 2004; 64:3892 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-03-2904; PMID: 15172999
   PubMed Web of Science ®Google Scholar
• Telang S, Yalcin A, Clem AL, Bucala R, Lane AN, Eaton JW, et al. Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene 2006; 25:7225 - 34; http://dx.doi.org/10.1038/sj.onc.1209709; PMID: 16715124
   PubMed Web of Science ®Google Scholar
• Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321:1807 - 12; http://dx.doi.org/10.1126/science.1164382; PMID: 18772396
   PubMed Web of Science ®Google Scholar
• Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP, et al. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 2009; 30:7 - 11; http://dx.doi.org/10.1002/humu.20937; PMID: 19117336
   PubMed Web of Science ®Google Scholar
• Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 2009; 324:261 - 5; http://dx.doi.org/10.1126/science.1170944; PMID: 19359588
   PubMed Web of Science ®Google Scholar
• Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009; 462:739 - 44; http://dx.doi.org/10.1038/nature08617; PMID: 19935646
   PubMed Web of Science ®Google Scholar
• Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E. Energy metabolism in tumor cells. FEBS J 2007; 274:1393 - 418; http://dx.doi.org/10.1111/j.1742-4658.2007.05686.x; PMID: 17302740
   PubMed Web of Science ®Google Scholar
• Pelicano H, Xu RH, Du M, Feng L, Sasaki R, Carew JS, et al. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol 2006; 175:913 - 23; http://dx.doi.org/10.1083/jcb.200512100; PMID: 17158952
   PubMed Web of Science ®Google Scholar
• Fogal V, Richardson AD, Karmali PP, Scheffler IE, Smith JW, Ruoslahti E. Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol 2010; 30:1303 - 18; http://dx.doi.org/10.1128/MCB.01101-09; PMID: 20100866
   PubMed Web of Science ®Google Scholar
• Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 2011; 25:460 - 70; http://dx.doi.org/10.1101/gad.2016311; PMID: 21317241
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Tanowitz HB, Sotgia F, et al. Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. Int J Biochem Cell Biol 2011; 43:1045 - 51; http://dx.doi.org/10.1016/j.biocel.2011.01.023; PMID: 21300172
   PubMed Web of Science ®Google Scholar
• Migneco G, Whitaker-Menezes D, Chiavarina B, Castello-Cros R, Pavlides S, Pestell RG, et al. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling. Cell Cycle 2010; 9:2412 - 22; http://dx.doi.org/10.4161/cc.9.12.11989; PMID: 20562527
   PubMed Web of Science ®Google Scholar
• Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, Chiavarina B, et al. Ketones and lactate “fuel” tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010; 9:3506 - 14; http://dx.doi.org/10.4161/cc.9.17.12731; PMID: 20818174
   PubMed Web of Science ®Google Scholar
• Sonveaux P, Végran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008; 118:3930 - 42; PMID: 19033663
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Prisco M, Ertel A, Tsirigos A, Lin Z, Pavlides S, et al. Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics. Cell Cycle 2011; 10:1271 - 86; http://dx.doi.org/10.4161/cc.10.8.15330; PMID: 21512313
   PubMed Web of Science ®Google Scholar
• Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011; 17:1498 - 503; http://dx.doi.org/10.1038/nm.2492; PMID: 22037646
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Whitaker-Menezes D, Pavlides S, Chiavarina B, Bonuccelli G, Casey T, et al. The autophagic tumor stroma model of cancer or “battery-operated tumor growth”: A simple solution to the autophagy paradox. Cell Cycle 2010; 9:4297 - 306; http://dx.doi.org/10.4161/cc.9.21.13817; PMID: 21051947
   PubMed Web of Science ®Google Scholar
• Riccio A, Del Prato S, Vigili de Kreutzenberg S, Tiengo A. Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin. Diabete Metab 1991; 17:180 - 4; PMID: 1936473
   PubMed Web of Science ®Google Scholar
• Deng YT, Huang HC, Lin JK. Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling. Mol Carcinog 2010; 49:141 - 51; PMID: 19777565
   PubMed Web of Science ®Google Scholar
• Wolvetang EJ, Johnson KL, Krauer K, Ralph SJ, Linnane AW. Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett 1994; 339:40 - 4; http://dx.doi.org/10.1016/0014-5793(94)80380-3; PMID: 8313978
   PubMed Web of Science ®Google Scholar
• Dong LF, Low P, Dyason JC, Wang XF, Prochazka L, Witting PK, et al. Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 2008; 27:4324 - 35; http://dx.doi.org/10.1038/onc.2008.69; PMID: 18372923
   PubMed Web of Science ®Google Scholar
• Xiao D, Powolny AA, Singh SV. Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells. J Biol Chem 2008; 283:30151 - 63; http://dx.doi.org/10.1074/jbc.M802529200; PMID: 18768478
   PubMed Web of Science ®Google Scholar
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006; 5:493 - 506; http://dx.doi.org/10.1038/nrd2060; PMID: 16732220
   PubMed Web of Science ®Google Scholar
• Eagle H. Nutrition needs of mammalian cells in tissue culture. Science 1955; 122:501 - 14; http://dx.doi.org/10.1126/science.122.3168.501; PMID: 13255879
   PubMed Web of Science ®Google Scholar
• Kovacević Z, Morris HP. The role of glutamine in the oxidative metabolism of malignant cells. Cancer Res 1972; 32:326 - 33; PMID: 4400467
   PubMed Web of Science ®Google Scholar
• Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab 2012; 15:110 - 21; http://dx.doi.org/10.1016/j.cmet.2011.12.009; PMID: 22225880
   PubMed Web of Science ®Google Scholar
• Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 2010; 35:427 - 33; http://dx.doi.org/10.1016/j.tibs.2010.05.003; PMID: 20570523
   PubMed Web of Science ®Google Scholar
• Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005; 8:311 - 21; http://dx.doi.org/10.1016/j.ccr.2005.09.008; PMID: 16226706
   PubMed Web of Science ®Google Scholar
• Carvalho MA, Zecchin KG, Seguin F, Bastos DC, Agostini M, Rangel AL, et al. Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int J Cancer 2008; 123:2557 - 65; http://dx.doi.org/10.1002/ijc.23835; PMID: 18770866
   PubMed Web of Science ®Google Scholar
• Orita H, Coulter J, Lemmon C, Tully E, Vadlamudi A, Medghalchi SM, et al. Selective inhibition of fatty acid synthase for lung cancer treatment. Clin Cancer Res 2007; 13:7139 - 45; PMID: 18056164
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 2007; 104:19345 - 50; http://dx.doi.org/10.1073/pnas.0709747104; PMID: 18032601
   PubMed Web of Science ®Google Scholar
• Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol 2007; 178:93 - 105; http://dx.doi.org/10.1083/jcb.200703099; PMID: 17606868
   PubMed Web of Science ®Google Scholar
• Meng M, Chen S, Lao T, Liang D, Sang N. Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells. Cell Cycle 2010; 9:3921 - 32; http://dx.doi.org/10.4161/cc.9.19.13139; PMID: 20935507
   PubMed Web of Science ®Google Scholar
• Gaglio D, Soldati C, Vanoni M, Alberghina L, Chiaradonna F. Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts. PLoS One 2009; 4:e4715; http://dx.doi.org/10.1371/journal.pone.0004715; PMID: 19262748
   PubMed Web of Science ®Google Scholar
• Lessner HE, Valenstein S, Kaplan R, DeSimone P, Yunis A. Phase II study of L-asparaginase in the treatment of pancreatic carcinoma. Cancer Treat Rep 1980; 64:1359 - 61; PMID: 7471124
   PubMedGoogle Scholar
• Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinis RJ, Zhao F, et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 2007; 67:6745 - 52; http://dx.doi.org/10.1158/0008-5472.CAN-06-4447; PMID: 17638885
   PubMed Web of Science ®Google Scholar
• Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009; 136:521 - 34; http://dx.doi.org/10.1016/j.cell.2008.11.044; PMID: 19203585
   PubMed Web of Science ®Google Scholar
• Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458:762 - 5; http://dx.doi.org/10.1038/nature07823; PMID: 19219026
   PubMed Web of Science ®Google Scholar
• Wang JB, Erickson JW, Fuji R, Ramachandran S, Gao P, Dinavahi R, et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 2010; 18:207 - 19; http://dx.doi.org/10.1016/j.ccr.2010.08.009; PMID: 20832749
   PubMed Web of Science ®Google Scholar
• Moreadith RW, Lehninger AL. The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. J Biol Chem 1984; 259:6215 - 21; PMID: 6144677
   PubMed Web of Science ®Google Scholar
• Thornburg JM, Nelson KK, Clem BF, Lane AN, Arumugam S, Simmons A, et al. Targeting aspartate aminotransferase in breast cancer. Breast Cancer Res 2008; 10:R84; http://dx.doi.org/10.1186/bcr2154; PMID: 18922152
   PubMed Web of Science ®Google Scholar
• Lieberman BP, Ploessl K, Wang L, Qu W, Zha Z, Wise DR, et al. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine. J Nucl Med 2011; 52:1947 - 55; http://dx.doi.org/10.2967/jnumed.111.093815; PMID: 22095958
   PubMed Web of Science ®Google Scholar
• Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 2009; 325:1555 - 9; http://dx.doi.org/10.1126/science.1174229; PMID: 19661383
   PubMed Web of Science ®Google Scholar
• Chen V, Staub RE, Fong S, Tagliaferri M, Cohen I, Shtivelman E. Bezielle selectively targets mitochondria of cancer cells to inhibit glycolysis and OXPHOS. PLoS One 2012; 7:e30300; http://dx.doi.org/10.1371/journal.pone.0030300; PMID: 22319564
   PubMedGoogle Scholar
• Cheong JH, Park ES, Liang J, Dennison JB, Tsavachidou D, Nguyen-Charles C, et al. Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models. Mol Cancer Ther 2011; 10:2350 - 62; http://dx.doi.org/10.1158/1535-7163.MCT-11-0497; PMID: 21992792
   PubMed Web of Science ®Google Scholar